Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03865589 · ClinicalTrials.gov registry record · NA

Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

A NA study of Stem Cell Transplant Complications and Bone Marrow Transplant Complications, sponsored by Children's Mercy Hospital Kansas City.

Active
Registry status
NA
Development phase
250
Enrollment target
7
Study locations

NCT03865589 is a NA study of Stem Cell Transplant Complications and Bone Marrow Transplant Complications that is active but no longer recruiting, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 250 participants, above the 169-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (48% higher). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03865589, a NA study of Stem Cell Transplant Complications and Bone Marrow Transplant Complications, is active but no longer recruiting, sponsored by Children's Mercy Hospital Kansas City.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
7
Study locations

Study Summary

To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obstruction syndrome (SOS), mild to moderate SOS, and severe to very severe SOS. Secondarily, the investigators would also like to quantify the temporal relationship between US SWE changes and SOS diagnosis according to various clinical criteria (Modified Seattle, Baltimore, EBMT consortium).

Interventions

  • DIAGNOSTIC_TEST Ultrasound Elastography

Study Locations (7)

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland
  • Nationwide Children's Hospital - Columbus

California

  • University of California, San Francisco - San Francisco

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Missouri

  • Children's Mercy - Kansas City

North Carolina

  • Duke University - Durham

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2019-04-01
Est. Completion 2027-06-30
Phase NA

What the Registry Record Tells You About NCT03865589

The ClinicalTrials.gov registry entry for NCT03865589 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 169-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (48% higher). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Stem Cell Transplant Complications appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Elastography is the first listed.

NCT03865589 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Ohio, California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03865589 about?

NCT03865589 is a clinical study titled "Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome". To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obs...

What is the current status of trial NCT03865589?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2019-04-01. Estimated completion is 2027-06-30.

What conditions does trial NCT03865589 study?

This clinical trial studies the following conditions: Stem Cell Transplant Complications, Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic.

What interventions are being tested in trial NCT03865589?

The interventions under investigation include: Ultrasound Elastography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03865589?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03865589 being conducted?

This trial has 7 study locations across California, Massachusetts, Missouri, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stem Cell Transplant Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.